SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bruce Rosen who wrote (2568)2/27/1998 9:49:00 AM
From: Tokyo VD  Read Replies (2) of 7041
 
Bruce,

Oh, by the way, you said that only the 40 mg dose is being used in the open label trials. THIS IS A LIE (intentionally or unintentionally). The two doses offered to patients are 40 mg and 80 mg. Furthermore, you assert that the 80 mg dose will not be used and the 40 mg dose is the only dosage that will be prescribed. My question for you is why did Zonagen report a success rate for the 80 mg dose (it was 48%) in the Phase III study that dispensed the 80 mg dose as a safety measure?

Tokyo
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News